The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Moderate Alcohol Use Could Be Safe with Methotrexate for RA

Moderate Alcohol Use Could Be Safe with Methotrexate for RA

April 13, 2017 • By Scott Baltic

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—In patients taking methotrexate for rheumatoid arthritis (RA), moderate alcohol consumption – that is, no higher than existing U.K. guidelines for the general population – was not associated with an increased risk of transaminitis, researchers say.

You Might Also Like
  • Moderate Alcohol Intake Decreases SLE Risk in Women
  • Alcohol Use Complicates Chronic Disease Management in Teens
  • Higher Tocilizumab Dose Plus Methotrexate Best for Early RA
Also By This Author
  • Existing CT Scans as Good as DXA for Assessing Hip Fracture Risk

The study is both the largest to examine alcohol and methotrexate (MTX) and the first to look at how the amount of alcohol affects hepatotoxicity in patients taking long-term MTX, corresponding author Dr. William G. Dixon, of the University of Manchester, told Reuters Health by email.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although the risk of transaminitis in patients with RA taking MTX was found to increase with increasing alcohol consumption, the risk in those patients who consumed no more than 14 units of alcohol per week was no greater than in those who do not drink alcohol, the researchers reported online March 23 in Annals of the Rheumatic Diseases.

U.K. guidelines recommend the consumption of no more than 14 units of alcohol per week, by men or women. A “unit” of alcohol is defined as 10 ml or 8 g of pure alcohol.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Fourteen units of alcohol equals six pints of 4% beer, six glasses of 13% wine, or 14 (25 ml) glasses of 40% spirits, according to the Drinkaware website.

In comparison, guidelines from the U.S. Centers for Disease Control and Prevention indicate that moderate alcohol use is up to 1 drink for a woman and 2 drinks for a man, on any single day. “Drink” definitions are similar to those used in the United Kingdom.

Their findings, the researchers wrote, “may provide the practical and useful information that drinking alcohol within nationally recommended levels in the UK is safe, in terms of risk of transaminitis, for patients commencing MTX therapy for RA.” Including these acceptable alcohol levels in clinical guidelines and informing patients of them, they added, could improve decision-making, clinical outcomes and overall quality of life.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The current uncertainty, Dr. Dixon said, “means that patients often avoid alcohol altogether, or avoid methotrexate if they want to continue to drink, even modestly.”

The authors cautioned, however, that their findings should not be generalized to other populations. For example, previous research has suggested that patients with psoriasis may have a higher incidence of liver disease compared to patients with RA.

One expert who was not connected to the study raised another caveat. Dr. Joel Kremer, of Albany Medical Center in upstate New York, thinks the study’s threshold for transaminitis – i.e., alanine transaminase or aspartate aminotransferase at least three times the upper limit of normal (ULN) – is much too high.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: Methotrexate, moderate alcohol consumption, MTX, Rheumatoid Arthritis (RA), transaminitis

You Might Also Like:
  • Moderate Alcohol Intake Decreases SLE Risk in Women
  • Alcohol Use Complicates Chronic Disease Management in Teens
  • Higher Tocilizumab Dose Plus Methotrexate Best for Early RA
  • Tofacitinib with Methotrexate Not Inferior to Adalimumab with Methotrexate

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)